NCT04974593View on ClinicalTrials.gov

Predictive Value of Hydrogen/methane Lactose Breath Testing on the Therapeutic Effect of Lactose-free Diet in Moderate to Severe ROME IV IBS.

PHASE3RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 22, 2021

Primary Completion Date

January 1, 2028

Study Completion Date

January 1, 2028

Conditions
Irritable Bowel SyndromeLactose Intolerant
Interventions
OTHER

low fat diet

A trained dietitian will provide instruction of the LFD according to standard practice.

Trial Locations (1)

1090

RECRUITING

UZ Brussel, Jette

All Listed Sponsors
lead

Universitair Ziekenhuis Brussel

OTHER